Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

Australia’s Therapeutic Goods Administration has approved a drug called donanemab for people in the early stages of Alzheimer ...

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

Zhong Nanshan, a noted expert on respiratory illness, said his team is now actively developing antibodies to COVID-19, aiming ...

GUANGZHOU: Zhong Nanshan (pic), a noted expert on respiratory illness, said his team is now actively developing antibodies to ...

Elevated LDH and higher international prognostic index were also predictors of poor outcomes on bispecific antibodies, ...

In THRIVE, Abrams' group recruited participants with moderate-to-severe active thyroid eye disease with proptosis at least 3 ...

Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.